降脂药物用于治疗脱脂症:叙述性综述
Majed S Alqahtani1, Khalid F Alzibali2, Abdulaziz Mahdi M Mahdi3
1Family Medicine and Diabetes Management, King Fahad Specialized Hospital, Tabuk, SAU.
Cureus
|August 23, 2024
概括
脱脂症是一种脂质失衡,显著增加了心血管疾病的风险. 有效的管理需要改变生活方式和各种降脂药物,需要进行持续的研究来确认有效性和安全性.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 脱脂症涉及异常的血脂水平 (甘油三,胆固醇),这是心血管疾病 (CVD) 的主要危险因素.
- 管理策略整合了生活方式的改变和针对脂质代谢的药物治疗.
研究的目的:
- 审查关于失脂症管理的当前文献.
- 分析各种降脂药物的疗效和不良事件.
- 检查国际治疗指南和未来的治疗方向.
主要方法:
- 在PubMed数据库中进行文献搜索.
- 对失脂症,治疗药物,疗效和不良事件的研究的综述.
- 对国际治疗指南的分析.
主要成果:
- 确定了作为主要治疗的他类药物,以及其他药物,包括纤维酸,欧米茄-3脂肪酸,ezetimibe,胆酸分离剂,PCSK9抑制剂和bempedoic酸.
- 审查了这些药物的有效性参数和常见不良事件.
- 讨论了国际指导方针和降脂疗法的未来趋势.
结论:
- 脱脂症的综合管理涉及生活方式的改变和各种药物药物.
- 进一步的研究是必要的,以验证新兴的降脂药物的有效性和安全性.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
601
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
601
Lipids: Dietary Sources and Requirements
709
Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
709
Cholesterol: Significance and Regulation
520
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
520
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
167
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
167
Blood Studies for Cardiovascular System III: Serum Lipid Profile
140
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
140
Diabetes: Management and Pharmacotherapy
245
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
245


